Skip to main content
OpenTrials
Completed

NCT Number: NCT04451096

Probiotics-prebiotic Fiber Therapy in Parkinson's Disease Patients With Constipation

A double blinded randomised placebo controlled trial to evaluate the efficacy of probiotics on constipation symptoms and whole gut transit time in patients with Parkinson's disease.PD patients with constipation were randomized to receive a multi-strain probiotic (Lactobacillus spp and Bifidobacterium spp at 30 X 109 CFU) with fructo-oligosaccaride (FOS) or placebo (fermented milk) twice daily for 8 weeks. Primary outcomes include changes in the presence of constipation symptoms using 9 items of Garrigues Questionnaire (GQ), which included an item on bowel opening frequency. Secondary and exploratory outcomes include whole gut transit time (WGTT), quality of life (PDQ39-SI), motor (MDS-UPDRS) and non-motor symptoms (NMSS).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Hospital Canselor Tuanku Muhriz, UKM Medical Center

Kuala Lumpur, 56000, Malaysia

About this study

This was an eight-week double-blind, randomized placebo-controlled intervention study involving 55 idiopathic PD patients attending tertiary hospital. This study was conducted in accordance with good clinical practice as per Declaration of Helsinki and was approved by the institution's Research and Ethics Committee (FF-2018-387). Written informed consent was obtained from all particpants prior to enrollment.

Participants were included if they were aged 18 or older; were diagnosed with idiopathic PD in Hoehn and Yahr stages 1-4, and fulfilled the Rome III criteria for functional constipation which requires the presence of recurrent abdominal pain 3 days per month in the last 3 months, and symptom onset 6 months prior to diagnosis, with additional criteria below to be fulfilled, as adapted from Longstreth, et al12.

  • Must include two or more of the following:
  • Straining during at least 25% of defecations
  • Lumpy or hard stools in at least 25% of defecations
  • Sensation of incomplete evacuation for at least 25% of defecations d. Sensation of anorectal obstruction/blockage for at least 25% of defecations

e. Manual maneuvers to facilitate at least 25% of defecations (e.g, digital evacuation, support of the pelvic floor) f. Fewer than 3 defecations per week

  • Loose stools are rarely present without the use of laxatives
  • There are insufficient criteria for IBS

Participants were excluded if they had: a MMSE score of ≤ 21/30; a positive stool occult blood screening; a diagnosis of secondary parkinsonism; previous history of small and large bowel disease; prior history of gastrointestinal tract surgery; use of probiotics or antibiotics two weeks prior to baseline visit; been on medications such as antidepressants or anticholinergics; history of lactose intolerance; concomitant diagnosis of hypothyroidism and diabetes mellitus.

All participants were assessed at baseline and at 8 weeks following intervention for all outcome assessments. At baseline, additional data on demographics (age, sex, educational level), duration of PD, dopaminergic medication, Hoehn & Yahr Scoring during ON period, and the level of physical activity were recorded at baseline. A sedentary behaviour was defined as being physically active < 4 hours /week.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 or older; were diagnosed with idiopathic PD
  • PD with Hoehn and Yahr stages 1-4,
  • Fulfilled the Rome III criteria for functional constipation

Exclusion criteria

  • MMSE score of ≤ 21/30
  • Positive stool occult blood screening
  • Diagnosis of secondary parkinsonism
  • Previous history of small and large bowel disease
  • History of gastrointestinal tract surgery
  • Use of probiotics or antibiotics two weeks prior to baseline visit
  • Been on medications such as antidepressants or anticholinergics
  • History of lactose intolerance
  • Concomitant diagnosis of hypothyroidism and diabetes mellitus.

Treatment and study plan

Probiotics with prebiotic

Dietary Supplement

Patients were instructed to consume one sachet twice daily mixed with a glass of water, before or after meals, for a duration of 8 weeks

Other names: Multistrain Probiotics with prebiotic

Placebo

Dietary Supplement

Patients were instructed to consume one sachet twice daily mixed with a glass of water, before or after meals, for a duration of 8 weeks

Other names: Granulated milk products

Primary outcomes

  1. constipation symptoms

    Time frame: 8 weeks

    The presence of constipation symptoms at baseline and at 8 weeks evaluated by

    Garrigues Questionnaire (GQ).GQ is a 21-item self-reported screening questionnaire to detect the presence of constipation symptoms, using two different sets of four-point Likert scale responses.Although 12 items assess bowel habits, 9 items specifically assess constipation symptoms and were used in our evaluation: (i)Feeling of blockage in the anus;(ii) Need to press around anus/vagina to complete bowel movement; (iii) Spend >10 minutes to pass stool;(iv) Straining during bowel movement;(v) Feeling of hard stool;(vi) Feeling of incomplete emptying sensation; (vii)Bowel opening frequency;(viii) Frequency of oral laxative use;(ix) Frequency of enema use

Secondary outcomes

  1. Whole Gut Transit Time (WGTT) in hours

    Time frame: 8 weeks

    WGTT was measured at baseline and at the end of 8 weeks, using red carmine capsule. The mean change in the WGTT (WGTT 8 weeks - WGTT baseline) was compared between the two groups.

  2. Frequency of patients with constipation (Bowel motion < 3 per week) in percentage

    Time frame: 8 weeks

    Based on the stool diary, the percentage of patients who experienced less than 3 BM per week was calculated at baseline and at the end of study.

  3. Movement Disorders Society- Unified Parkinson's Disease Rating Scale Part 11

    Time frame: 8 weeks

    This measures the motor aspects of activity of daily living and consists of 13 items with scores between 0- 52. This instrument is given at baseline and 8 weeks. Lower score indicates low severity

  4. Movement Disorders Society- Unified Parkinson's Disease Rating Scale Part 111

    Time frame: 8 weeks

    This measures the seveirty of motor symptoms using 18 items (score 0-72). This instrument is given at baseline and 8 weeks. Lower score indicates low severity.

  5. Non motor symptom score

    Time frame: 8 weeks

    Change in non-motor symptoms severity scores using the Non motor Symptom Scale (NMSS) which consists of 9 domains (cardiovascular, sleep/fatigue, mood/cognition, perceptual problems/hallucination, attention/memory, gastrointestinal tract, urinary, sexual function and miscellaneous.Score ranges from minimum of 3 to 360. Lower score indicates lower severity

  6. Parkinsons Disease Quality of Life -39 Summary Index (PDQ39SI)

    Time frame: 8 weeks

    Change in PD9 39-SI which measure 8 domains of Quality of Life ( Lower score indicates better quality of life)

  7. Weight in kilogram

    Time frame: 8 weeks

    Change in body weight measurement in Kg

  8. Height in metres

    Time frame: Baseline

    Height will be measured in meters at baseline

  9. Body Mass Index (kg/m2)

    Time frame: 8 weeks

    Weight and height will be combined to report BMI in kg/m^

Sponsors and collaborators

Lead sponsor

National University of Malaysia

Other

Registry information

Official study title

Probiotics-prebiotic Fiber Therapy Improved Bowel Opening Frequency and Whole Gut Transit Time in Parkinson's Disease Patients With Constipation: A Randomised Controlled Study

Important dates

Study start
2018
Primary completion
2019
Study completion
2019
First posted
Jun 30, 2020
Registry last updated
Jun 30, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.